Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2021
U.S. FDA Drug Approvals for Breast Cancer: A Decade in ReviewShaily Arora, Preeti Narayan, Christy L Osgood, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2020
FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or Metastatic HER2-positive Breast CancerMirat Shah, Suparna Wedam, Joyce Cheng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021
Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case ExamplesAnup K Amatya, Mallorie H Fiero, Erik W Bloomquist, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2023
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With <i>BRCA</i>-Mutated Metastatic Castration-Resistant Prostate CancerJaleh Fallah, Jianjin Xu, Chana Weinstock, et al.Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Integrating 4 Measures to Evaluate Physical Function in Patients with Cancer (In4M): Protocol for a prospective studyGita Thanarajasingam, Paul G Kluetz, Vishal Bhatnagar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2021
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in ReviewShaily Arora, Preeti Narayan, Gwynn Ison, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2025
FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-unresponsive carcinoma in situBrian L Heiss, Elaine Chang, Hee-Koung Joeng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian CancerAsma Dilawari, Mirat Shah, Gwynn Ison, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2025
FDA Approval Summary: Niraparib Plus Abiraterone Acetate Fixed Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate CancerWilliam F Maguire, Dow-Chung Chi, Sundeep Agrawal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2024
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, <i>ESR1</i>-Mutated Advanced or Metastatic Breast CancerMirat Shah, Hima Lingam, Xin Gao, et al.Pageof 5